These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 2288838

  • 21. Diuretic effect and diuretic efficiency after intravenous dosage of frusemide.
    Alván G, Helleday L, Lindholm A, Sanz E, Villén T.
    Br J Clin Pharmacol; 1990 Feb; 29(2):215-9. PubMed ID: 2306413
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Determination and interpretation of the diuretic equivalence of azosemid and furosemide].
    Gerová Z, Nándoryová M, Dzúrik R.
    Vnitr Lek; 1982 Mar; 28(3):266-73. PubMed ID: 6896778
    [No Abstract] [Full Text] [Related]

  • 25. [Features of the pharmacodynamics and pharmacokinetics of furosemide upon long-term administration in rats].
    Briukhanov VM, Zverev IaF, Lampatov VV, Zharikov AIu.
    Eksp Klin Farmakol; 2007 Mar; 70(2):33-6. PubMed ID: 17523448
    [Abstract] [Full Text] [Related]

  • 26. Furosemide pharmacokinetics and pharmacodynamics following gastroretentive dosage form administration to healthy volunteers.
    Klausner EA, Lavy E, Stepensky D, Cserepes E, Barta M, Friedman M, Hoffman A.
    J Clin Pharmacol; 2003 Jul; 43(7):711-20. PubMed ID: 12856384
    [Abstract] [Full Text] [Related]

  • 27. Population pharmacokinetic modeling of furosemide in patients with hypertension and fluid overload conditions.
    Kodati D, Yellu N.
    Pharmacol Rep; 2017 Jun; 69(3):492-496. PubMed ID: 28340405
    [Abstract] [Full Text] [Related]

  • 28. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
    Sanjay S, Annigeri RA, Seshadri R, Rao BS, Prakash KC, Mani MK.
    Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
    [Abstract] [Full Text] [Related]

  • 29. [Pharmacodynamics of piretanide in compromised kidney function. Dose response relationship and equipotency with furosemide].
    Keller E, Reetze-Bonorden P, Rambauseck M, Pooth R.
    Internist (Berl); 1992 Aug; 33 Suppl 1():S36-8. PubMed ID: 1428696
    [No Abstract] [Full Text] [Related]

  • 30. Nonrelevant Pharmacokinetic Drug-Drug Interaction Between Furosemide and Pindolol Enantiomers in Hypertensive Parturient Women.
    Gonçalves PVB, Moreira FL, Benzi JRL, Cavalli RC, Duarte G, Lanchote VL.
    J Clin Pharmacol; 2020 Nov; 60(11):1527-1529. PubMed ID: 32789919
    [No Abstract] [Full Text] [Related]

  • 31. Effect of a hepatoprotective agent, YH-439, on the pharmacokinetics of furosemide and azosemide in rats.
    Kim SH, Park KJ, Yoon WH, Lee JW, Kim ND, Lee MG.
    Res Commun Mol Pathol Pharmacol; 1996 Feb; 91(2):233-44. PubMed ID: 8832915
    [Abstract] [Full Text] [Related]

  • 32. Determination of bioequivalence of two furosemide preparations; the effect of high doses of furosemide on some pharmacokinetic parameters.
    Wolf-Coporda A, Lovrić Z, Huić M, Francetić I, Vrhovac B, Plavsić F, Skreblin M.
    Int J Clin Pharmacol Res; 1996 Feb; 16(4-5):83-8. PubMed ID: 9172005
    [Abstract] [Full Text] [Related]

  • 33. Mechanism of ascorbic acid enhancement of the bioavailability and diuretic effect of furosemide.
    Lee MG, Chiou WL.
    Drug Metab Dispos; 1998 May; 26(5):401-7. PubMed ID: 9571221
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure.
    Pivac N, Rumboldt Z, Sardelić S, Bagatin J, Polić S, Ljutić D, Naranca M, Capkun V.
    Int J Clin Pharmacol Res; 1998 May; 18(3):121-8. PubMed ID: 9825268
    [Abstract] [Full Text] [Related]

  • 37. Statistical evaluation of the regulatory guidelines for use of furosemide in race horses.
    Chu KK, Wang N, Stanley S, Cohen ND.
    Biometrics; 2001 Mar; 57(1):294-301. PubMed ID: 11252613
    [Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics of furosemide administered 4 and 24 hours prior to high-speed exercise in horses.
    Knych HK, Vale A, Wilson WD, Kass PH, Arthur RM, Jones JH.
    J Vet Pharmacol Ther; 2018 Apr; 41(2):224-229. PubMed ID: 29057472
    [Abstract] [Full Text] [Related]

  • 39. Input rate as a major determinant of furosemide pharmacodynamics: influence of fluid replacement and hypoalbuminemia.
    Castañeda-Hernández G, Vergés J, Pichette V, Héroux L, Caillé G, du Souich P.
    Drug Metab Dispos; 2000 Mar; 28(3):323-8. PubMed ID: 10681377
    [Abstract] [Full Text] [Related]

  • 40. Enhanced Both in vitro and in vivo Kinetics by SLNs Induced Transdermal System of Furosemide: A Novel Approach.
    Mannam R, Yallamalli IM.
    Recent Pat Drug Deliv Formul; 2017 Mar; 11(3):187-197. PubMed ID: 29189185
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.